AV Peptide | Thymosin alpha 1 - Pen
Recommended dosage: 20 to 24 units per day.
Pen capacity: 200 clicks.
Course of administration: 7-10 days.
Thymosin alpha 1 is a peptide vital to the human immune system. It is produced by thymus cells and is considered one of the most important peptides for normal bodily function. It plays a key role in fighting infections, stimulating phagocytosis and enhancing immune cell function, which leads to a reduction in inflammation and increased cell regeneration. In medicine, this peptide is used to treat various diseases, such as hepatitis, HIV, cancer, systemic lupus erythematosus, rheumatoid arthritis, and Sjögren's syndrome. Patients taking Thymosin alpha 1 have shown positive effects in combating these diseases.
What are the benefits of Thymosin alpha 1?
Thymosin alpha 1 peptide has significant positive effects on the immune system, including:
✔ Strengthening the body's immune response through the production of immune cells and hormones.
✔ This peptide plays a key role in fighting bacterial, viral, fungal, and other infections.
✔ Reduces inflammation in the body by regulating the production of inflammatory mediators.
✔ Stimulates the body's fight against cancer cells.
✔ Helps treat various autoimmune diseases, such as systemic lupus erythematosus, Sjögren's syndrome, and rheumatoid arthritis.
✔ This peptide may promote healthy aging by helping manage issues such as oxidative stress and decreased immunity.
✔ Increases the effectiveness of antibiotics in treating infections.
✔ It can enhance the effect of vaccines in the body by improving the immune response.
✔ Helps improve immunity by promoting the development and maturation of various immune system cells, which leads to improved immune function and the body's ability to fight various diseases and infections.
Thymosin alpha 1 Clinical Trials and Results:
Thymosin alpha 1 is a small peptide hormone that plays a crucial role in the body's immune system.
The results of numerous clinical trials show that the peptide Thymosin alpha 1 has a positive effect on the treatment of cancer, hepatitis, HIV, and sepsis. It may be an adjunctive therapeutic agent supporting the treatment of a specific disease. A consultation with a specialist is necessary to determine its effectiveness in a specific case.
Proper Use and Dosage of Thymosin alpha 1:
The correct route of administration and dosage of Thymosin alpha 1 depend on the specific needs and goals of the patient. Typically, 500 to 600 mcg is administered once daily. The recommended dose of Thymosin alpha 1 is 20 to 24 units per day.
Additional instructions for use: Set the pen programmer to 20 or 24 (1 unit corresponds to one division on the programmer) and inject into the abdomen or front of the thigh. After the injection, wait 10 seconds before removing the needle. Rotating the injection site is recommended.
The duration of a cycle of use of this peptide is approximately 7 days, depending on the user's goals.
The pen contains 200 units of 25 mcg.
One Thymosin Alpha 1 pen (5 mg) will last approximately 10 days, depending on the daily dose.
Examples of units for the Thymosin alpha 1 pen (5 mg), corresponding to micrograms:
1 unit = 25 mcg;
10 units = 250 mcg;
20 units = 500 mcg;
24 units = 600 mcg.
